Cargando…
Erythropoietin Combined with Liposomal Amphotericin B Improves Outcome during Disseminated Aspergillosis in Mice
Disseminated aspergillosis is responsible for a high mortality rate, despite the use of antifungal drugs. Adjuvant therapies are urgently needed to improve the outcome. The aim of this study was to demonstrate that the cytoprotective effect of erythropoietin (EPO) combined with amphotericin B can re...
Autores principales: | Rousseau, Nathalie, Picot, Stephane, Bienvenu, Anne-Lise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4196557/ https://www.ncbi.nlm.nih.gov/pubmed/25352847 http://dx.doi.org/10.3389/fimmu.2014.00502 |
Ejemplares similares
-
Successful Multimodal Therapy with Intracerebral Liposomal Amphotericin B and Systemic High-Dose Isavuconazole in Proven Disseminated Aspergillosis
por: Feys, Simon, et al.
Publicado: (2023) -
Successful Treatment of Disseminated Fusariosis with the Combination of Voriconazole and Liposomal Amphotericin B
por: Efe İris, Nur, et al.
Publicado: (2016) -
Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment
por: Borges, Ana Flávia, et al.
Publicado: (2021) -
Liposomal amphotericin B-induced reversible ototoxicity in a patient with disseminated histoplasmosis
por: Ramu, Ramadoss, et al.
Publicado: (2021) -
Amphotericin-B-liposomal: No improvement: case report
Publicado: (2022)